On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
FridayJun 30, 2017 9:14 am

SinglePoint (SING) Interview Discusses Key Aspects of Recently Announced Bitcoin Joint Venture

SING targets the large and rapidly growing multi-billion dollar retail cannabis sales industry New agreement provides efficient and easy-to-apply solution to critical unmet need Purchasing model opens door to additional opportunities for investor profit in cannabis An iPod interview with SinglePoint president Wil Ralston (http://nnw.fm/pi9GN) covers the significant advantages that the company’s recently announced joint venture with First Bitcoin Capital Corp. (OTC: BITCF) represents for the cannabis industry.  In a study of 20 U.S. jurisdictions by Greenwave Advisors, legal marijuana represented $6.5 billion in retail sales by May 2017, as reported by Forbes (http://nnw.fm/zs8S6). At the current level of growth,…

Continue Reading

ThursdayJun 29, 2017 3:59 pm

Future Farm Technologies, Inc. (CSE: FFT) (OTCQB: FFRMF) Launches Its New and Expanded Interactive Website

LED lighting producer and leading indoor plant growth solutions provider Focused on efficiencies for the legal cannabis industry Website is now SEO-optimized, providing an easier way to order product Future Farm Technologies, Inc. (CSE: FFT) (OTCQB: FFRMF) has fully updated and SEO-optimized its e-commerce website (www.LEDCanada.com) in response to rising consumer demand for LED grow lights. The new and expanded site has gone live, and the LED product line can be viewed on LEDCanada.com. The site now contains a number of social media buttons for Facebook, Twitter, and Pinterest. The LEDCanada.com website will be updated with the newest content from…

Continue Reading

ThursdayJun 29, 2017 1:36 pm

ChineseInvestors.com (CIIX) Achieves Exciting Firsts in the Global Cannabis Market

Launched world’s first Chinese language online CBD health products store Launched world’s first Chinese language mobile cannabis navigation app Positioned to become first company in China to use CBD oil in treating epilepsy and Alzheimer’s Pursuing its aim of becoming the leading publicly traded Chinese medical marijuana company, ChineseInvestors.com, Inc. (OTCQB: CIIX) continues its focus on investing in distribution and R&D of cannabidiol-based (CBD) medicines and health products targeted at Chinese-speaking clients throughout the world. Marijuana use is currently illegal in China, but cannabis-based oils, including hemp-based CBD, are legal, giving CIIX access to a market of almost two billion…

Continue Reading

ThursdayJun 29, 2017 10:15 am

Algae Dynamics Corp. (ADYNF) Continues Cannabis Oil Research as Potential Marijuana Shortage Looms in Canada

A 1,000-fold increase in the Canadian cannabis oil extraction market is expected, with growth from C$1 million in 2015 to an expected C$1.7 billion by 2020 The Canadian market is expected to see a conversion rate of 45 percent, which is similar to trends in Colorado, based on a Mackie Research Capital study The Government of Canada expects to fully legalize marijuana nationwide on or before July 2018 Investors have had their eyes on Algae Dynamics Corp. (OTCQB: ADYNF), which has partnered with various Canadian universities (including the University of Waterloo and Western University) for access to research and to…

Continue Reading

WednesdayJun 28, 2017 1:53 pm

India Globalization Capital, Inc. (NYSE: IGC) at the Threshold of a Potential Alzheimer’s Breakthrough

Alzheimer’s is the most ominous and expensive disease in the U.S. IGC is the first and only NYSE MKT-listed pharmaceutical company to develop cannabis-based Alzheimer's therapies IGC’s patent pending phytocannabinoid therapies to enter clinical trials for potential Alzheimer’s breakthrough A pioneer in the development of innovative cannabis-based combination therapies, India Globalization Capital (NYSE MKT: IGC) is creating new classes of phytocannabinoid pharmaceuticals with broad therapeutic applications for both humans and animals. IGC’s pipeline of patent pending therapeutics include treatments for pain, cachexia, neurologic disorders, Parkinson’s and Alzheimer’s disease. IGC plans to enter clinical trials this year on its primary pipeline…

Continue Reading

WednesdayJun 28, 2017 9:00 am

Bitcoin and Hydroponics Present Prime Investment Opportunities in the Legal Cannabis Space

CannabisNewsWire Editorial Coverage: In increasing volume, investment opportunities in the legalized marijuana industry are being added to the portfolio of many enterprising investors. Amid the numerous categories of investment options offered within this burgeoning industry, two sectors stand out: bitcoin, a digital currency that can facilitate the transfer of funds free of banks and government regulation, and hydroponics, an industry standard method of growing plants without soil. Companies like SinglePoint, Inc. (SING) (SING Profile), Bitcoin Investment Trust (GBTC), First Bitcoin Capital Corp. (BITCF), Scott’s Miracle-Gro Co. (SMG) and Terra Tech Corp. (TRTC) are currently forging paths in these increasingly popular…

Continue Reading

TuesdayJun 27, 2017 2:27 pm

Invictus MD (OTC: IVITF) (TSX.V: IMH): A Cannabis Company Living Up to its Name

Canadian Cannabis Valuations up 200% in two years 250 acres of cultivation space stretching from Alberta to Ontario Paid out $1,000,000 in Dividends representing $0.07 per Share It might just be that Invictus MD Strategies Corp. (OTC: IVITF) (TSX.V: IMH) (FRA: 8IS) has adopted as a motto the elevating penultimate line from William Ernest Henley’s immortal poem Invictus: “I am the master of my fate”. Canada’s Cannabis Company appears completely unafraid as it ploughs ahead with its strategy to become a dominant company in Canada’s cannabis space. That boldness is paying off; Invictus is one of only a handful of…

Continue Reading

MondayJun 26, 2017 2:52 pm

InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Targeting Blockbuster Therapeutics

The medical efficacy of cannabinoids to treat a multiplicity of maladies is no longer in doubt. Two recently published scientific studies dispelled any apprehensions about cannabis-based therapies. The highly respected New England Journal of Medicine published a peer reviewed article that proved in a controlled study that cannabidiol dramatically reduced the number of convulsive seizures in children stricken with a severe epileptic disorder (http://nnw.fm/i0X0D). The results of this study follow a comprehensive report by the National Academies of Science, Engineering, and Medicine which confirmed that cannabinoids are effective at treating chronic pain and for providing relief from nausea and vomiting…

Continue Reading

MondayJun 26, 2017 8:54 am

SinglePoint’s (SING) $1M Promissory Note Furthers Efforts to Offer Bitcoin Payment Solution for Cannabis Businesses

Furthering its efforts to innovate solutions for the cannabis industry, SinglePoint, Inc. (OTC: SING) has taken a step forward in its endeavor to offer a bitcoin payments solution for cannabis businesses through its partnership with First Bitcoin Capital Corp. (OTC: BITCF). SinglePoint recently announced (http://nnw.fm/dS8l3) it has successfully closed a $1 million convertible promissory note with an institutional investor — the proceeds from which will be used to fund the company’s bitcoin payments endeavor and will enable SinglePoint to move quickly in developing a cryptocurrency solution and continuing its acquisitions activities in the cannabis space. A lack of banking options…

Continue Reading

ThursdayJun 22, 2017 3:41 pm

InMed Pharmaceuticals (CSE: IN) (OTCQB: IMLFF) Takes Additional Step toward Clinical Trials for INM-750

Moving toward offering the very first therapy for treating epidermolysis bullosa (EB), InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) recently announced it has signed an agreement with Pharmaseed Ltd. (http://nnw.fm/4lZzC) to develop a final formulation for INM-750, InMed’s lead compound, which is being developed as a therapy for EB and for other potential dermatological and wound-healing applications. EB is a group of inherited connective tissue diseases sharing a common manifestation of very fragile skin that is prone to easily blistering or tearing. An orphan disease that currently has no approved treatments and has significant unmet medical need, EB results from…

Continue Reading

Contact us: 303.498.7722